| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | guanyl-nucleotide exchange factor activity | PLEKHG7 RAPGEF4 RALGPS2 PSD3 RASGEF1A PREX2 TIAM2 RASGRP1 RALGPS1 RASGEF1B ARHGEF4 RAPGEF2 RAPGEFL1 PLCE1 | 4.95e-09 | 231 | 159 | 14 | GO:0005085 |
| GeneOntologyMolecularFunction | aspartic-type endopeptidase activity | 4.40e-07 | 37 | 159 | 6 | GO:0004190 | |
| GeneOntologyMolecularFunction | aspartic-type peptidase activity | 5.19e-07 | 38 | 159 | 6 | GO:0070001 | |
| GeneOntologyMolecularFunction | RNA-DNA hybrid ribonuclease activity | 1.22e-06 | 11 | 159 | 4 | GO:0004523 | |
| GeneOntologyMolecularFunction | voltage-gated sodium channel activity | 1.73e-06 | 26 | 159 | 5 | GO:0005248 | |
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | PLEKHG7 RAPGEF4 RALGPS2 PSD3 RASGEF1A PREX2 TIAM2 RASGRP1 TBC1D22A RALGPS1 RASGEF1B ARHGEF4 ARHGAP27 RAPGEF2 RAPGEFL1 PLCE1 | 3.06e-06 | 507 | 159 | 16 | GO:0060589 |
| GeneOntologyMolecularFunction | GTPase regulator activity | PLEKHG7 RAPGEF4 RALGPS2 PSD3 RASGEF1A PREX2 TIAM2 RASGRP1 TBC1D22A RALGPS1 RASGEF1B ARHGEF4 ARHGAP27 RAPGEF2 RAPGEFL1 PLCE1 | 3.06e-06 | 507 | 159 | 16 | GO:0030695 |
| GeneOntologyMolecularFunction | RNA-directed DNA polymerase activity | 3.64e-06 | 14 | 159 | 4 | GO:0003964 | |
| GeneOntologyMolecularFunction | DNA polymerase activity | 1.22e-05 | 38 | 159 | 5 | GO:0034061 | |
| GeneOntologyMolecularFunction | nuclease activity | ERVK-6 REXO4 NTHL1 POLE WRN ERVK-7 ERVK-10 ERI2 ERVK-8 HELZ2 | 1.68e-05 | 231 | 159 | 10 | GO:0004518 |
| GeneOntologyMolecularFunction | RNA stem-loop binding | 2.08e-05 | 21 | 159 | 4 | GO:0035613 | |
| GeneOntologyMolecularFunction | armadillo repeat domain binding | 4.02e-05 | 9 | 159 | 3 | GO:0070016 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on DNA | 4.90e-05 | 262 | 159 | 10 | GO:0140097 | |
| GeneOntologyMolecularFunction | sodium channel activity | 5.78e-05 | 52 | 159 | 5 | GO:0005272 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on a nucleic acid | PMS1 ERVK-6 NTHL1 POLE WRN CHD8 ERVK-7 MSH3 ERVK-10 ERI2 METTL1 IARS2 TRMT44 ERVK-8 HELZ2 DHX29 | 5.91e-05 | 645 | 159 | 16 | GO:0140640 |
| GeneOntologyMolecularFunction | UDP-glucose:glycoprotein glucosyltransferase activity | 6.30e-05 | 2 | 159 | 2 | GO:0003980 | |
| GeneOntologyMolecularFunction | sodium ion transmembrane transporter activity | 6.95e-05 | 171 | 159 | 8 | GO:0015081 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on ester bonds | ERVK-6 REXO4 NTHL1 POLE WRN BCHE ERVK-7 ERVK-10 ERI2 NDST3 PTPN4 IARS2 PPP2R5A PTPN13 ERVK-8 HELZ2 G6PC1 PLCE1 | 7.91e-05 | 807 | 159 | 18 | GO:0016788 |
| GeneOntologyMolecularFunction | 3'-5' exonuclease activity | 1.25e-04 | 61 | 159 | 5 | GO:0008408 | |
| GeneOntologyMolecularFunction | type II activin receptor binding | 1.88e-04 | 3 | 159 | 2 | GO:0070699 | |
| GeneOntologyMolecularFunction | RNA endonuclease activity, producing 5'-phosphomonoesters | 2.08e-04 | 37 | 159 | 4 | GO:0016891 | |
| GeneOntologyMolecularFunction | enzyme regulator activity | NOLC1 PLEKHG7 RAPGEF4 RALGPS2 PSD3 RASGEF1A PREX2 TIAM2 RASGRP1 ARL1 FRY CDK5R1 PPP2R5A SERPINE2 TBC1D22A RALGPS1 RASGEF1B C3 SERPINC1 ARHGEF4 ARHGAP27 RAPGEF2 RAPGEFL1 PLCE1 | 3.60e-04 | 1418 | 159 | 24 | GO:0030234 |
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 3.70e-04 | 18 | 159 | 3 | GO:0008569 | |
| GeneOntologyMolecularFunction | beta-1 adrenergic receptor binding | 3.74e-04 | 4 | 159 | 2 | GO:0031697 | |
| GeneOntologyMolecularFunction | endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters | 4.87e-04 | 46 | 159 | 4 | GO:0016893 | |
| GeneOntologyMolecularFunction | RNA nuclease activity | 7.78e-04 | 136 | 159 | 6 | GO:0004540 | |
| GeneOntologyMolecularFunction | endonuclease activity | 7.78e-04 | 136 | 159 | 6 | GO:0004519 | |
| GeneOntologyMolecularFunction | exonuclease activity | 8.46e-04 | 92 | 159 | 5 | GO:0004527 | |
| GeneOntologyMolecularFunction | dynein light intermediate chain binding | 1.40e-03 | 28 | 159 | 3 | GO:0051959 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on RNA | ERVK-6 ERVK-7 ERVK-10 ERI2 METTL1 IARS2 TRMT44 ERVK-8 HELZ2 DHX29 | 1.91e-03 | 417 | 159 | 10 | GO:0140098 |
| GeneOntologyMolecularFunction | oxidized purine DNA binding | 2.72e-03 | 10 | 159 | 2 | GO:0032357 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | 2.87e-03 | 441 | 159 | 10 | GO:0016887 | |
| GeneOntologyBiologicalProcess | Ras protein signal transduction | RAPGEF4 RALGPS2 RASGEF1A ITPKB RASGRP1 RALGPS1 RASGEF1B RAPGEF2 RAPGEFL1 PLCE1 | 5.80e-08 | 128 | 159 | 10 | GO:0007265 |
| GeneOntologyBiologicalProcess | DNA synthesis involved in DNA repair | 8.00e-08 | 48 | 159 | 7 | GO:0000731 | |
| GeneOntologyBiologicalProcess | DNA repair | PMS1 ERVK-6 REXO4 STUB1 SEM1 NTHL1 POLE WRN BARD1 ERVK-7 MSH3 ERVK-10 ZBTB7A ERVK-8 PWWP3A ZFYVE26 TAF5 USP1 TADA3 USP47 | 1.39e-07 | 648 | 159 | 20 | GO:0006281 |
| GeneOntologyBiologicalProcess | small GTPase-mediated signal transduction | OGT PLEKHG7 RAPGEF4 RALGPS2 PSD3 RASGEF1A PREX2 TIAM2 ITPKB RASGRP1 RALGPS1 RASGEF1B ARHGEF4 ARHGAP27 RAPGEF2 RAPGEFL1 PLCE1 | 9.37e-07 | 538 | 159 | 17 | GO:0007264 |
| GeneOntologyBiologicalProcess | DNA integration | 2.30e-06 | 13 | 159 | 4 | GO:0015074 | |
| GeneOntologyBiologicalProcess | DNA metabolic process | PMS1 ERVK-6 REXO4 STUB1 SEM1 NTHL1 POLE WRN BARD1 ERVK-7 MSH3 ERVK-10 LIN9 ORC1 ZBTB7A NFIA NFIC ERVK-8 PWWP3A ZFYVE26 TAF5 USP1 TADA3 USP47 | 2.86e-06 | 1081 | 159 | 24 | GO:0006259 |
| GeneOntologyBiologicalProcess | membrane depolarization during action potential | 7.94e-06 | 36 | 159 | 5 | GO:0086010 | |
| GeneOntologyBiologicalProcess | neuronal action potential | 9.02e-06 | 63 | 159 | 6 | GO:0019228 | |
| GeneOntologyBiologicalProcess | DNA damage response | PMS1 ERVK-6 REXO4 STUB1 SEM1 NTHL1 POLE WRN BARD1 ERVK-7 MSH3 ERVK-10 ZBTB7A ERVK-8 PWWP3A ZFYVE26 MAEL TAF5 USP1 TADA3 USP47 | 1.57e-05 | 959 | 159 | 21 | GO:0006974 |
| GeneOntologyBiologicalProcess | detection of mechanical stimulus | 2.48e-05 | 75 | 159 | 6 | GO:0050982 | |
| GeneOntologyBiologicalProcess | UDP-glucosylation | 5.91e-05 | 2 | 159 | 2 | GO:0097359 | |
| GeneOntologyBiologicalProcess | DNA-templated DNA replication | 7.36e-05 | 178 | 159 | 8 | GO:0006261 | |
| GeneOntologyBiologicalProcess | cardiac muscle cell action potential involved in contraction | 1.16e-04 | 62 | 159 | 5 | GO:0086002 | |
| GeneOntologyBiologicalProcess | DNA replication | 1.59e-04 | 312 | 159 | 10 | GO:0006260 | |
| GeneOntologyBiologicalProcess | sodium ion transmembrane transport | 2.16e-04 | 208 | 159 | 8 | GO:0035725 | |
| GeneOntologyBiologicalProcess | regulation of receptor localization to synapse | 2.27e-04 | 39 | 159 | 4 | GO:1902683 | |
| GeneOntologyBiologicalProcess | transmission of nerve impulse | 2.33e-04 | 112 | 159 | 6 | GO:0019226 | |
| GeneOntologyBiologicalProcess | regulation of small GTPase mediated signal transduction | OGT PSD3 RASGEF1A PREX2 TIAM2 ITPKB RASGRP1 RALGPS1 ARHGEF4 ARHGAP27 | 2.68e-04 | 333 | 159 | 10 | GO:0051056 |
| GeneOntologyBiologicalProcess | sodium ion transport | SCN11A SERPINE2 SLC20A1 SCN1A SCN4A SCN8A SCN10A SLC24A1 SLC4A5 | 2.91e-04 | 275 | 159 | 9 | GO:0006814 |
| GeneOntologyBiologicalProcess | DNA biosynthetic process | 2.96e-04 | 218 | 159 | 8 | GO:0071897 | |
| GeneOntologyCellularComponent | voltage-gated sodium channel complex | 1.37e-07 | 17 | 159 | 5 | GO:0001518 | |
| GeneOntologyCellularComponent | sodium channel complex | 2.45e-06 | 29 | 159 | 5 | GO:0034706 | |
| GeneOntologyCellularComponent | C-fiber | 3.42e-04 | 4 | 159 | 2 | GO:0044299 | |
| Domain | RASGEF_CAT | RAPGEF4 RALGPS2 RASGEF1A RASGRP1 RALGPS1 RASGEF1B RAPGEF2 RAPGEFL1 PLCE1 | 1.36e-12 | 29 | 156 | 9 | PS50009 |
| Domain | RasGEF | RAPGEF4 RALGPS2 RASGEF1A RASGRP1 RALGPS1 RASGEF1B RAPGEF2 RAPGEFL1 PLCE1 | 1.93e-12 | 30 | 156 | 9 | PF00617 |
| Domain | - | RAPGEF4 RALGPS2 RASGEF1A RASGRP1 RALGPS1 RASGEF1B RAPGEF2 RAPGEFL1 PLCE1 | 1.93e-12 | 30 | 156 | 9 | 1.10.840.10 |
| Domain | RASGEF_cat_dom | RAPGEF4 RALGPS2 RASGEF1A RASGRP1 RALGPS1 RASGEF1B RAPGEF2 RAPGEFL1 PLCE1 | 1.93e-12 | 30 | 156 | 9 | IPR001895 |
| Domain | RasGEF | RAPGEF4 RALGPS2 RASGEF1A RASGRP1 RALGPS1 RASGEF1B RAPGEF2 RAPGEFL1 PLCE1 | 1.93e-12 | 30 | 156 | 9 | SM00147 |
| Domain | Ras_GEF_dom | RAPGEF4 RALGPS2 RASGEF1A RASGRP1 RALGPS1 RASGEF1B RAPGEF2 RAPGEFL1 PLCE1 | 1.93e-12 | 30 | 156 | 9 | IPR023578 |
| Domain | RASGEF | RAPGEF4 RALGPS2 RASGEF1A RASGRP1 RALGPS1 RASGEF1B RAPGEFL1 PLCE1 | 2.72e-11 | 26 | 156 | 8 | PS00720 |
| Domain | Na_channel_asu | 9.29e-09 | 10 | 156 | 5 | IPR001696 | |
| Domain | Na_trans_assoc | 9.29e-09 | 10 | 156 | 5 | IPR010526 | |
| Domain | Na_trans_assoc | 9.29e-09 | 10 | 156 | 5 | PF06512 | |
| Domain | RasGEFN | 5.34e-07 | 20 | 156 | 5 | SM00229 | |
| Domain | RasGEF_N | 6.96e-07 | 21 | 156 | 5 | PF00618 | |
| Domain | Ras-like_Gua-exchang_fac_N | 8.95e-07 | 22 | 156 | 5 | IPR000651 | |
| Domain | RASGEF_NTER | 8.95e-07 | 22 | 156 | 5 | PS50212 | |
| Domain | PH_dom-like | PLEKHG7 RALGPS2 PSD3 PREX2 TIAM2 JAK1 PTPN4 PTPN13 CMIP RALGPS1 ARHGEF4 ARHGAP27 EPB41L1 PLCE1 | 1.40e-05 | 426 | 156 | 14 | IPR011993 |
| Domain | RNaseH-like_dom | 2.39e-05 | 69 | 156 | 6 | IPR012337 | |
| Domain | Ubiquitin-rel_dom | RAPGEF4 PTPN4 PTPN13 SACS RAPGEF2 EPB41L1 USP47 RAPGEFL1 PLCE1 | 2.47e-05 | 184 | 156 | 9 | IPR029071 |
| Domain | PRT_C | 6.93e-05 | 2 | 156 | 2 | PF08372 | |
| Domain | UDP-g_GGtrans | 6.93e-05 | 2 | 156 | 2 | IPR009448 | |
| Domain | UDP-g_GGTase | 6.93e-05 | 2 | 156 | 2 | PF06427 | |
| Domain | PRibTrfase_C | 6.93e-05 | 2 | 156 | 2 | IPR013583 | |
| Domain | - | PLEKHG7 RALGPS2 PSD3 PREX2 TIAM2 PTPN4 PTPN13 RALGPS1 ARHGEF4 ARHGAP27 EPB41L1 PLCE1 | 1.12e-04 | 391 | 156 | 12 | 2.30.29.30 |
| Domain | Channel_four-helix_dom | 1.12e-04 | 57 | 156 | 5 | IPR027359 | |
| Domain | - | 1.12e-04 | 57 | 156 | 5 | 1.20.120.350 | |
| Domain | PDZ | 1.84e-04 | 141 | 156 | 7 | PF00595 | |
| Domain | Dynein_heavy_chain_D4_dom | 1.94e-04 | 14 | 156 | 3 | IPR024317 | |
| Domain | Dynein_heavy_dom-2 | 1.94e-04 | 14 | 156 | 3 | IPR013602 | |
| Domain | DHC_N2 | 1.94e-04 | 14 | 156 | 3 | PF08393 | |
| Domain | ATPase_dyneun-rel_AAA | 1.94e-04 | 14 | 156 | 3 | IPR011704 | |
| Domain | AAA_8 | 1.94e-04 | 14 | 156 | 3 | PF12780 | |
| Domain | AAA_5 | 1.94e-04 | 14 | 156 | 3 | PF07728 | |
| Domain | Striatin_N | 2.07e-04 | 3 | 156 | 2 | IPR013258 | |
| Domain | Striatin | 2.07e-04 | 3 | 156 | 2 | PF08232 | |
| Domain | DHC_fam | 2.42e-04 | 15 | 156 | 3 | IPR026983 | |
| Domain | Dynein_heavy | 2.42e-04 | 15 | 156 | 3 | PF03028 | |
| Domain | Dynein_heavy_dom | 2.42e-04 | 15 | 156 | 3 | IPR004273 | |
| Domain | PDZ | 2.48e-04 | 148 | 156 | 7 | SM00228 | |
| Domain | - | 2.69e-04 | 150 | 156 | 7 | 2.30.42.10 | |
| Domain | PDZ | 2.80e-04 | 151 | 156 | 7 | PS50106 | |
| Domain | PDZ | 2.91e-04 | 152 | 156 | 7 | IPR001478 | |
| Domain | CTF_NFI | 4.11e-04 | 4 | 156 | 2 | PF00859 | |
| Domain | CTF_NFI_1 | 4.11e-04 | 4 | 156 | 2 | PS00349 | |
| Domain | CTF_NFI_2 | 4.11e-04 | 4 | 156 | 2 | PS51080 | |
| Domain | CTF/NFI_DNA-bd-dom | 4.11e-04 | 4 | 156 | 2 | IPR020604 | |
| Domain | NfI_DNAbd_pre-N | 4.11e-04 | 4 | 156 | 2 | PF10524 | |
| Domain | CTF/NFI | 4.11e-04 | 4 | 156 | 2 | IPR000647 | |
| Domain | CTF/NFI_DNA-bd_N | 4.11e-04 | 4 | 156 | 2 | IPR019548 | |
| Domain | CTF/NFI_DNA-bd_CS | 4.11e-04 | 4 | 156 | 2 | IPR019739 | |
| Domain | PH | PLEKHG7 RALGPS2 PSD3 PREX2 TIAM2 CMIP RALGPS1 ARHGEF4 ARHGAP27 | 5.59e-04 | 278 | 156 | 9 | SM00233 |
| Domain | PH_DOMAIN | PLEKHG7 RALGPS2 PSD3 PREX2 TIAM2 CMIP RALGPS1 ARHGEF4 ARHGAP27 | 5.74e-04 | 279 | 156 | 9 | PS50003 |
| Domain | PH_domain | PLEKHG7 RALGPS2 PSD3 PREX2 TIAM2 CMIP RALGPS1 ARHGEF4 ARHGAP27 | 5.89e-04 | 280 | 156 | 9 | IPR001849 |
| Domain | - | 6.32e-04 | 47 | 156 | 4 | 3.30.420.10 | |
| Domain | FERM_central | 7.41e-04 | 49 | 156 | 4 | IPR019748 | |
| Domain | FERM_domain | 7.41e-04 | 49 | 156 | 4 | IPR000299 | |
| Domain | FERM_1 | 8.00e-04 | 50 | 156 | 4 | PS00660 | |
| Domain | FERM_2 | 8.00e-04 | 50 | 156 | 4 | PS00661 | |
| Domain | FERM_3 | 8.00e-04 | 50 | 156 | 4 | PS50057 | |
| Domain | Band_41_domain | 8.00e-04 | 50 | 156 | 4 | IPR019749 | |
| Domain | B41 | 8.00e-04 | 50 | 156 | 4 | SM00295 | |
| Domain | C2 | 8.17e-04 | 131 | 156 | 6 | PF00168 | |
| Domain | Na_trans_cytopl | 1.02e-03 | 6 | 156 | 2 | PF11933 | |
| Domain | Na_trans_cytopl | 1.02e-03 | 6 | 156 | 2 | IPR024583 | |
| Domain | C2 | 1.03e-03 | 137 | 156 | 6 | SM00239 | |
| Domain | C2 | 1.24e-03 | 142 | 156 | 6 | PS50004 | |
| Domain | FERM_C | 1.29e-03 | 26 | 156 | 3 | PF09380 | |
| Domain | AAA | 1.33e-03 | 144 | 156 | 6 | SM00382 | |
| Domain | AAA+_ATPase | 1.33e-03 | 144 | 156 | 6 | IPR003593 | |
| Domain | FERM_PH-like_C | 1.44e-03 | 27 | 156 | 3 | IPR018980 | |
| Domain | FERM_C | 1.44e-03 | 27 | 156 | 3 | SM01196 | |
| Domain | - | 1.53e-03 | 148 | 156 | 6 | 2.60.40.150 | |
| Domain | DH_1 | 1.90e-03 | 63 | 156 | 4 | PS00741 | |
| Domain | RhoGEF | 2.52e-03 | 68 | 156 | 4 | SM00325 | |
| Domain | C2_dom | 2.57e-03 | 164 | 156 | 6 | IPR000008 | |
| Domain | FERM_N | 2.59e-03 | 33 | 156 | 3 | IPR018979 | |
| Domain | FERM_N | 2.59e-03 | 33 | 156 | 3 | PF09379 | |
| Domain | Ion_trans_dom | 2.70e-03 | 114 | 156 | 5 | IPR005821 | |
| Domain | Ion_trans | 2.70e-03 | 114 | 156 | 5 | PF00520 | |
| Domain | RhoGEF | 2.80e-03 | 70 | 156 | 4 | PF00621 | |
| Domain | DH_2 | 2.80e-03 | 70 | 156 | 4 | PS50010 | |
| Domain | IQ | 2.95e-03 | 71 | 156 | 4 | PF00612 | |
| Domain | - | 2.95e-03 | 71 | 156 | 4 | 1.20.900.10 | |
| Domain | DH-domain | 2.95e-03 | 71 | 156 | 4 | IPR000219 | |
| Domain | PH | 3.16e-03 | 229 | 156 | 7 | PF00169 | |
| Domain | RA | 3.33e-03 | 36 | 156 | 3 | PF00788 | |
| Domain | DEAH_ATP_HELICASE | 3.89e-03 | 38 | 156 | 3 | PS00690 | |
| Domain | GDS_CDC24_CS | 4.19e-03 | 39 | 156 | 3 | IPR001331 | |
| Domain | MAD_homology1_Dwarfin-type | 4.33e-03 | 12 | 156 | 2 | IPR003619 | |
| Domain | DWA | 4.33e-03 | 12 | 156 | 2 | SM00523 | |
| Domain | MH1 | 4.33e-03 | 12 | 156 | 2 | PF03165 | |
| Domain | RA_dom | 4.50e-03 | 40 | 156 | 3 | IPR000159 | |
| Domain | FA | 5.09e-03 | 13 | 156 | 2 | PF08736 | |
| Domain | FERM-adjacent | 5.09e-03 | 13 | 156 | 2 | IPR014847 | |
| Domain | FA | 5.09e-03 | 13 | 156 | 2 | SM01195 | |
| Domain | Dynein_HC_stalk | 5.91e-03 | 14 | 156 | 2 | IPR024743 | |
| Domain | Ras_G-nucl-exch_fac_CS | 5.91e-03 | 14 | 156 | 2 | IPR019804 | |
| Domain | EXOIII | 5.91e-03 | 14 | 156 | 2 | SM00479 | |
| Domain | Exonuclease_RNaseT/DNA_pol3 | 5.91e-03 | 14 | 156 | 2 | IPR013520 | |
| Domain | RNase_T | 5.91e-03 | 14 | 156 | 2 | PF00929 | |
| Domain | MT | 5.91e-03 | 14 | 156 | 2 | PF12777 | |
| Domain | FERM_M | 6.67e-03 | 46 | 156 | 3 | PF00373 | |
| Pathway | REACTOME_INTERACTION_BETWEEN_L1_AND_ANKYRINS | 4.95e-06 | 31 | 116 | 5 | M877 | |
| Pathway | REACTOME_PHASE_0_RAPID_DEPOLARISATION | 5.83e-06 | 32 | 116 | 5 | M27455 | |
| Pathway | REACTOME_DISEASES_OF_DNA_REPAIR | 6.01e-05 | 51 | 116 | 5 | M29854 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SOD1_TO_RETROGRADE_AXONAL_TRANSPORT | 6.60e-05 | 27 | 116 | 4 | M47755 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | SLC12A6 BEST1 OGT WWP1 PAQR5 BARD1 FGFRL1 PCGF3 HPS3 ITPKB KIAA1671 THAP4 SLC7A1 ZBTB7A PTPN4 PTPN13 CMIP LRFN2 NFIA TBC1D22A NFIC RALGPS1 SETBP1 TANC1 ARHGEF4 RAPGEF2 MCTP2 SLC4A5 EPB41L1 BRMS1 | 1.89e-11 | 1489 | 165 | 30 | 28611215 |
| Pubmed | 2.81e-10 | 9 | 165 | 5 | 16382098 | ||
| Pubmed | REXO4 OGT NOC2L NTHL1 PIEZO1 WRN CKAP5 GON4L DIDO1 CHD8 SPECC1 LIN9 NSD3 PCF11 KIAA1671 ORC1 ZBTB7A STRN PTPN13 STRN4 HELZ2 TANC1 TAF5 DHX29 TADA3 EPB41L1 | 1.08e-08 | 1497 | 165 | 26 | 31527615 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | NOLC1 OGT NOC2L NTHL1 WRN NUP98 CKAP5 BARD1 NUP43 DIDO1 MSH3 LIN9 NSD3 ORC1 THAP4 ZBTB7A NFIA SUPT5H NFIC MKI67 SF3A3 TAF5 TADA3 BRMS1 | 1.22e-08 | 1294 | 165 | 24 | 30804502 |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | NOLC1 ERC1 HJURP RALGPS2 CKAP5 PSD3 SPECC1 NSD3 ITPKB KIAA1671 VPS13D C2CD3 PTPN13 TANC1 ARHGEF4 PEAK1 RAPGEF2 EPB41L1 AHNAK2 | 3.18e-08 | 861 | 165 | 19 | 36931259 |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | POLE WWP1 PIEZO1 FGFRL1 CHD8 ABCA7 TIAM2 NSD3 FOCAD ORC1 SLC7A1 CDK5R1 C2CD3 RALGPS1 SCN8A STRN4 HELZ2 ZFYVE26 TANC1 ARHGEF4 AHNAK2 | 7.25e-08 | 1105 | 165 | 21 | 35748872 |
| Pubmed | Many human endogenous retrovirus K (HERV-K) proviruses are unique to humans. | 4.18e-07 | 4 | 165 | 3 | 10469592 | |
| Pubmed | ERC1 CKAP5 PSD3 GON4L EPG5 FOCAD MAGI2 LRFN2 YY1AP1 ARHGEF4 EPB41L1 PLCE1 | 6.34e-07 | 407 | 165 | 12 | 12693553 | |
| Pubmed | PMS1 ERC1 UGGT1 NUP98 PSD3 NSD3 PCF11 KIAA1671 PTPN4 C2CD3 PPP2R5A VIPAS39 PTPN13 SUPT5H MKI67 TANC1 PEAK1 USP1 EPB41L1 | 6.56e-07 | 1049 | 165 | 19 | 27880917 | |
| Pubmed | OGT STUB1 ERC1 RAPGEF4 CKAP5 NUP43 MSH3 SPECC1 FOCAD JAK1 THAP4 MAGI2 FRY SERPINE2 PTPN13 SACS SUPT5H USP32 YY1AP1 RAPGEF2 USP47 | 8.56e-07 | 1285 | 165 | 21 | 35914814 | |
| Pubmed | A Rap guanine nucleotide exchange factor enriched highly in the basal ganglia. | 1.04e-06 | 5 | 165 | 3 | 9789079 | |
| Pubmed | Quantitation of HERV-K env gene expression and splicing in human breast cancer. | 1.04e-06 | 5 | 165 | 3 | 12629516 | |
| Pubmed | Interaction network of human early embryonic transcription factors. | OGT NUP98 NUP43 CHD8 MSH3 PCGF3 LIN9 KIAA1671 NFIA NFIC MKI67 | 1.04e-06 | 351 | 165 | 11 | 38297188 |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | PMS1 REXO4 OGT NTHL1 WRN BARD1 DIDO1 CHD8 MSH3 LIN9 NSD3 NFIA NFIC MKI67 | 1.38e-06 | 608 | 165 | 14 | 36089195 |
| Pubmed | 2.08e-06 | 6 | 165 | 3 | 16029194 | ||
| Pubmed | 2.08e-06 | 6 | 165 | 3 | 23711479 | ||
| Pubmed | A 'toothache tree' alkylamide inhibits Aδ mechanonociceptors to alleviate mechanical pain. | 2.08e-06 | 6 | 165 | 3 | 23652591 | |
| Pubmed | Comparative interactome analysis of α-arrestin families in human and Drosophila. | NOLC1 STUB1 WWP1 FGFRL1 FMNL3 JAK1 IARS2 PTPN13 SLC20A1 SF3A3 | 2.76e-06 | 313 | 165 | 10 | 38270169 |
| Pubmed | NOLC1 REXO4 NOC2L POLE UGGT1 NUP98 CKAP5 DIDO1 CHD8 IARS2 SUPT5H HELZ2 MKI67 USP47 | 3.15e-06 | 653 | 165 | 14 | 22586326 | |
| Pubmed | NOLC1 REXO4 OGT STUB1 NUP98 GON4L DIDO1 CHD8 PCGF3 LIN9 PCF11 KIAA1671 ZBTB7A BCAP31 NFIA NFIC MKI67 YY1AP1 TAF5 TADA3 BRMS1 | 4.52e-06 | 1429 | 165 | 21 | 35140242 | |
| Pubmed | The cell proliferation antigen Ki-67 organises heterochromatin. | OGT BARD1 DIDO1 CHD8 FMNL3 ZBTB7A ARL1 NFIC MKI67 SF3A3 PWWP3A | 4.64e-06 | 410 | 165 | 11 | 26949251 |
| Pubmed | NOLC1 REXO4 WRN NUP98 PCF11 KIAA1671 ARL1 IARS2 BCAP31 VIPAS39 PTPN13 MKI67 PWWP3A PEAK1 RAPGEF2 | 4.94e-06 | 777 | 165 | 15 | 35844135 | |
| Pubmed | A revised nomenclature for transcribed human endogenous retroviral loci. | 6.00e-06 | 94 | 165 | 6 | 21542922 | |
| Pubmed | Interaction proteome of human Hippo signaling: modular control of the co-activator YAP1. | 6.25e-06 | 270 | 165 | 9 | 24366813 | |
| Pubmed | PMS1 NOLC1 STUB1 NOC2L POLE PIEZO1 UGGT1 PSD3 PCF11 ARL1 IARS2 BCAP31 PTPN13 SACS SLC20A1 UGGT2 TANC1 PEAK1 DHX29 TADA3 EPB41L1 | 8.28e-06 | 1487 | 165 | 21 | 33957083 | |
| Pubmed | 8.63e-06 | 9 | 165 | 3 | 15746173 | ||
| Pubmed | PMS1 OGT POLE GON4L DIDO1 CHD8 ARL1 SUPT5H UGGT2 YY1AP1 TANC1 EPB41L1 PLCE1 | 1.50e-05 | 650 | 165 | 13 | 38777146 | |
| Pubmed | SLC12A6 OGT ERC1 RAPGEF4 CKAP5 PSD3 SPECC1 ITPKB MAGI2 STRN SACS STRN4 TANC1 ARHGEF4 PEAK1 RAPGEF2 DNAH6 DHX29 EPB41L1 DNAH11 | 1.60e-05 | 1431 | 165 | 20 | 37142655 | |
| Pubmed | 1.80e-05 | 33 | 165 | 4 | 21658281 | ||
| Pubmed | The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2. | WWP1 RALGPS2 PSD3 FGFRL1 SPECC1 SLC7A1 BCAP31 NRK USP32 TANC1 PEAK1 EPB41L1 | 1.92e-05 | 569 | 165 | 12 | 30639242 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | NOLC1 STUB1 NUP98 CKAP5 DIDO1 PCF11 ZBTB7A NFIA NFIC HELZ2 MKI67 YY1AP1 DHX29 USP47 | 2.13e-05 | 774 | 165 | 14 | 15302935 |
| Pubmed | Heat-resistant action potentials require TTX-resistant sodium channels NaV1.8 and NaV1.9. | 2.24e-05 | 2 | 165 | 2 | 29970412 | |
| Pubmed | Reduction of Kcnt1 is therapeutic in mouse models of SCN1A and SCN8A epilepsy. | 2.24e-05 | 2 | 165 | 2 | 37901435 | |
| Pubmed | RET signaling is required for survival and normal function of nonpeptidergic nociceptors. | 2.24e-05 | 2 | 165 | 2 | 20237269 | |
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 21478675 | ||
| Pubmed | An Scn1a epilepsy mutation in Scn8a alters seizure susceptibility and behavior. | 2.24e-05 | 2 | 165 | 2 | 26410685 | |
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 24144460 | ||
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 25835709 | ||
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 10694380 | ||
| Pubmed | A common sex-dependent mutation in a RET enhancer underlies Hirschsprung disease risk. | 2.24e-05 | 2 | 165 | 2 | 15829955 | |
| Pubmed | Newly identified Gon4l/Udu-interacting proteins implicate novel functions. | 2.24e-05 | 2 | 165 | 2 | 32848183 | |
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 15528213 | ||
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 28450535 | ||
| Pubmed | The transcriptional regulator GON4L is required for viability and hematopoiesis in mice. | 2.24e-05 | 2 | 165 | 2 | 33864850 | |
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 27543214 | ||
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 31943325 | ||
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 31534133 | ||
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 33320095 | ||
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 27496766 | ||
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 31053115 | ||
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 33826368 | ||
| Pubmed | The Justy mutation identifies Gon4-like as a gene that is essential for B lymphopoiesis. | 2.24e-05 | 2 | 165 | 2 | 20530203 | |
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 18399542 | ||
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 21422198 | ||
| Pubmed | Genetic variants of DNAH11 and LRFN2 genes and their association with ovarian and breast cancer. | 2.24e-05 | 2 | 165 | 2 | 31605628 | |
| Pubmed | NUP98 is fused to the NSD3 gene in acute myeloid leukemia associated with t(8;11)(p11.2;p15). | 2.24e-05 | 2 | 165 | 2 | 11986249 | |
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 31570756 | ||
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 34250384 | ||
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 33411788 | ||
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 19931571 | ||
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 21715335 | ||
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 34930944 | ||
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 16857712 | ||
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 24140206 | ||
| Pubmed | The Nav1.9 channel is a key determinant of cold pain sensation and cold allodynia. | 2.24e-05 | 2 | 165 | 2 | 25959819 | |
| Pubmed | Identifying candidate Hirschsprung disease-associated RET variants. | 2.24e-05 | 2 | 165 | 2 | 15759212 | |
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 12913004 | ||
| Pubmed | Both isoforms of human UDP-glucose:glycoprotein glucosyltransferase are enzymatically active. | 2.24e-05 | 2 | 165 | 2 | 24415556 | |
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 30590005 | ||
| Pubmed | Persistent Nav1.1 and Nav1.6 currents drive spinal locomotor functions through nonlinear dynamics. | 2.24e-05 | 2 | 165 | 2 | 37665666 | |
| Pubmed | Interferon-alpha-induced endogenous superantigen. a model linking environment and autoimmunity. | 2.24e-05 | 2 | 165 | 2 | 11672541 | |
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 17881658 | ||
| Pubmed | NOLC1 OGT STUB1 ERC1 WWP1 CHD8 ABCA7 NSD3 KIAA1671 JAK1 ZBTB7A PPP2R5A MCTP1 TANC1 TAF5 RAPGEF2 TADA3 | 2.49e-05 | 1116 | 165 | 17 | 31753913 | |
| Pubmed | NOC2L SEM1 CDHR1 HJURP NUP98 PSD3 FGFRL1 THAP4 CDK5R1 PPP2R5A VIPAS39 NFIC ZFYVE26 ARHGAP27 SLC24A1 USP1 | 2.60e-05 | 1006 | 165 | 16 | 15226823 | |
| Pubmed | 2.90e-05 | 13 | 165 | 3 | 15123669 | ||
| Pubmed | 3.21e-05 | 332 | 165 | 9 | 25693804 | ||
| Pubmed | 3.67e-05 | 14 | 165 | 3 | 9373155 | ||
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | NOLC1 OGT HJURP NUP98 CKAP5 NUP43 SPECC1 LIN9 PCF11 ORC1 STRN PPP2R5A BCAP31 STRN4 MKI67 SF3A3 USP47 | 3.82e-05 | 1155 | 165 | 17 | 20360068 |
| Pubmed | Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism. | 3.95e-05 | 341 | 165 | 9 | 32971831 | |
| Pubmed | 4.58e-05 | 15 | 165 | 3 | 33722956 | ||
| Pubmed | BEST1 FGFRL1 BCHE KIAA1671 FOCAD JAK1 MAGI2 CMIP SCN8A RASGEF1B ZFYVE26 YY1AP1 EPB41L1 AHNAK2 | 4.66e-05 | 832 | 165 | 14 | 36724073 | |
| Pubmed | A Large-scale genetic association study of esophageal adenocarcinoma risk. | 4.94e-05 | 351 | 165 | 9 | 20453000 | |
| Pubmed | NOLC1 SLC12A6 SCN11A NOC2L ERC1 UGGT1 NUP98 PCF11 STRN C2CD3 BCAP31 SACS SCN4A STRN4 CC2D2A UGGT2 ARHGEF4 USP1 DNAH6 | 5.85e-05 | 1442 | 165 | 19 | 35575683 | |
| Pubmed | SR protein kinases promote splicing of nonconsensus introns. | 6.13e-05 | 361 | 165 | 9 | 26167880 | |
| Pubmed | 6.69e-05 | 3 | 165 | 2 | 28381640 | ||
| Pubmed | 6.69e-05 | 3 | 165 | 2 | 28392395 | ||
| Pubmed | 6.69e-05 | 3 | 165 | 2 | 19645719 | ||
| Pubmed | 6.69e-05 | 3 | 165 | 2 | 30395542 | ||
| Pubmed | 6.69e-05 | 3 | 165 | 2 | 10548487 | ||
| Pubmed | 6.69e-05 | 3 | 165 | 2 | 12955085 | ||
| Pubmed | 6.69e-05 | 3 | 165 | 2 | 38999942 | ||
| Pubmed | 6.69e-05 | 3 | 165 | 2 | 25517131 | ||
| Pubmed | Conditional knockout of NaV1.6 in adult mice ameliorates neuropathic pain. | 6.69e-05 | 3 | 165 | 2 | 29497094 | |
| Pubmed | DNAH6 and Its Interactions with PCD Genes in Heterotaxy and Primary Ciliary Dyskinesia. | 6.69e-05 | 3 | 165 | 2 | 26918822 | |
| Pubmed | 6.69e-05 | 3 | 165 | 2 | 28209735 | ||
| Pubmed | 6.69e-05 | 3 | 165 | 2 | 19107198 | ||
| Pubmed | 6.69e-05 | 3 | 165 | 2 | 26182346 | ||
| Pubmed | De novo SCN1A, SCN8A, and CLCN2 mutations in childhood absence epilepsy. | 6.69e-05 | 3 | 165 | 2 | 31054517 | |
| Pubmed | 6.69e-05 | 3 | 165 | 2 | 10085123 | ||
| Pubmed | 6.69e-05 | 3 | 165 | 2 | 16714450 | ||
| Interaction | YWHAB interactions | OGT ERC1 HJURP RALGPS2 PSD3 SPECC1 ITPKB KIAA1671 PTPN4 ARL1 VPS13D VIPAS39 PTPN13 CTPS2 TBC1D22A RALGPS1 USP32 TANC1 ARHGEF4 PEAK1 RAPGEF2 EPB41L1 USP47 AHNAK2 | 1.11e-06 | 1014 | 157 | 24 | int:YWHAB |
| Interaction | SCN11A interactions | 4.53e-06 | 15 | 157 | 4 | int:SCN11A | |
| Interaction | GOLGA1 interactions | 1.38e-05 | 183 | 157 | 9 | int:GOLGA1 | |
| Interaction | YWHAH interactions | NOLC1 OGT ERC1 HJURP RALGPS2 CKAP5 PSD3 SPECC1 NSD3 KIAA1671 PTPN4 ARL1 IARS2 VPS13D C2CD3 PTPN13 CC2D2A TANC1 ARHGEF4 PEAK1 RAPGEF2 EPB41L1 AHNAK2 | 1.51e-05 | 1102 | 157 | 23 | int:YWHAH |
| GeneFamily | Sodium voltage-gated channel alpha subunits | 8.97e-10 | 9 | 109 | 5 | 1203 | |
| GeneFamily | Dyneins, axonemal | 2.80e-06 | 17 | 109 | 4 | 536 | |
| GeneFamily | Multiple C2 and transmembrane domain containing | 3.60e-05 | 2 | 109 | 2 | 826 | |
| GeneFamily | UDP-glucose glycoprotein glucosyltransferases | 3.60e-05 | 2 | 109 | 2 | 440 | |
| GeneFamily | PDZ domain containing | 3.76e-05 | 152 | 109 | 7 | 1220 | |
| GeneFamily | WD repeat domain containing|Protein phosphatase 2 regulatory subunits | 9.20e-05 | 15 | 109 | 3 | 696 | |
| GeneFamily | Exonucleases | 1.13e-04 | 16 | 109 | 3 | 544 | |
| GeneFamily | Ankyrin repeat domain containing|FERM domain containing | 2.33e-04 | 50 | 109 | 4 | 1293 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 2.51e-04 | 206 | 109 | 7 | 682 | |
| GeneFamily | Cadherin related | 4.62e-03 | 17 | 109 | 2 | 24 | |
| GeneFamily | Ubiquitin specific peptidases | 4.69e-03 | 56 | 109 | 3 | 366 | |
| GeneFamily | Protein tyrosine phosphatases, non-receptor type | 5.17e-03 | 18 | 109 | 2 | 812 | |
| GeneFamily | Protein phosphatase catalytic subunits|STRIPAK complex | 6.37e-03 | 20 | 109 | 2 | 1371 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 7.41e-03 | 66 | 109 | 3 | 722 | |
| GeneFamily | PWWP domain containing | 7.69e-03 | 22 | 109 | 2 | 1147 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | PMS1 DPYD OGT ERC1 WWP1 WRN NUP98 CKAP5 PSD3 BARD1 MSH3 PCF11 SLC7A1 PTPN4 C2CD3 PPP2R5A PTPN13 SACS RAPGEF2 PLCE1 | 1.96e-07 | 856 | 156 | 20 | M4500 |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP | NOLC1 STUB1 NOC2L POLE HJURP CKAP5 NUP43 ERI2 LIN9 FMNL3 JAK1 ORC1 SERPINE2 MKI67 TAF5 USP1 | 3.92e-07 | 578 | 156 | 16 | M2368 |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP | NOLC1 STUB1 NOC2L POLE HJURP CKAP5 NUP43 ERI2 LIN9 FMNL3 JAK1 ORC1 SERPINE2 MKI67 TAF5 USP1 | 6.01e-07 | 597 | 156 | 16 | MM1309 |
| Coexpression | DESCARTES_MAIN_FETAL_HORIZONTAL_CELLS | 8.78e-06 | 47 | 156 | 5 | M40096 | |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN | OGT WWP1 WRN RALGPS2 FGFRL1 BCHE SPECC1 ABCA7 LIN9 FOCAD STRN VIPAS39 FBXO10 TBC1D22A NFIC RALGPS1 SCN8A RASGEF1B EPB41L1 BRMS1 | 9.27e-06 | 1102 | 156 | 20 | M2369 |
| Coexpression | DAZARD_RESPONSE_TO_UV_NHEK_DN | 1.34e-05 | 300 | 156 | 10 | M8702 | |
| Coexpression | DESCARTES_MAIN_FETAL_ERYTHROBLASTS | 1.70e-05 | 245 | 156 | 9 | M40073 | |
| Coexpression | WAKASUGI_HAVE_ZNF143_BINDING_SITES | 1.75e-05 | 54 | 156 | 5 | M9575 | |
| Coexpression | E2F1_UP.V1_UP | 1.77e-05 | 188 | 156 | 8 | M2632 | |
| Coexpression | BENPORATH_CYCLING_GENES | OGT HJURP NUP98 CKAP5 BARD1 NUP43 ABCA7 PCF11 ORC1 ZBTB7A NFIA NFIC MKI67 USP1 | 3.51e-05 | 648 | 156 | 14 | M8156 |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN | OGT WWP1 WRN RALGPS2 FGFRL1 BCHE SPECC1 ABCA7 LIN9 FOCAD STRN FBXO10 TBC1D22A NFIC RALGPS1 SCN8A RASGEF1B EPB41L1 BRMS1 | 4.16e-05 | 1124 | 156 | 19 | MM1070 |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro1_(4)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 2.91e-08 | 190 | 159 | 9 | 7986586b7c82e91c71102cc8c4d7a689ae63ab4d | |
| ToppCell | NS-moderate-d_07-13-Epithelial-FOXN4+|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 9.97e-08 | 157 | 159 | 8 | 410c9d74a2085179cfb39853cb6d330fa98c9c1b | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_G2M|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.29e-07 | 175 | 159 | 8 | 3e56695a9db97cb1d3503425c48eb79bbf99213e | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Endothelial-leukocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.23e-07 | 183 | 159 | 8 | 919c9861073d12fd12aecd7469b1478b13838c43 | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 6.09e-07 | 199 | 159 | 8 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-DC-DC1-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.28e-06 | 166 | 159 | 7 | c8a7d94ed762e5e045ab5f74eef691ddc5f74993 | |
| ToppCell | 3'-Distal_airway-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.47e-06 | 168 | 159 | 7 | de0b00bc405c898d08a06b2e585fb62c0ab9a66e | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.62e-06 | 178 | 159 | 7 | b169aa5eaa51730daaec69c6bc58126be1592a50 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.05e-06 | 181 | 159 | 7 | aa233b652921848af2257cc3687a7a09c3acfb67 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c11-MKI67-FOS|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.35e-06 | 183 | 159 | 7 | ba7753e9fe2a6a87c5264f299ac97da2ddbda178 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Epithelial-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.51e-06 | 184 | 159 | 7 | 264e14aa1859cfc0ed5fb40e97ea189aed9ef4a5 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Epithelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.51e-06 | 184 | 159 | 7 | d7eccbd21c480d907fdc8eff2bf5ae22ae452221 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Epithelial-neuroepithelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.51e-06 | 184 | 159 | 7 | 22010cfe0428ebfa40952cc1a1a12ad3d25b35c9 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.67e-06 | 185 | 159 | 7 | 34fcfd635c828dad9643bbf1c908d79282d6f5d9 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.67e-06 | 185 | 159 | 7 | 8816f2909ed11833ff3d0ed96b9cb6d6fe9e1578 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Artery|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.76e-06 | 191 | 159 | 7 | 4b3d5157344dbfbf4fab518611cd9fa37fac7bd9 | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-Gen_Cap|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.17e-06 | 193 | 159 | 7 | e09387af84d2a0a526e54d4793e6e06c6739db53 | |
| ToppCell | Control-Endothelial-Endothelial|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.17e-06 | 193 | 159 | 7 | aff0649c73c634bc6ff0dc7759b4693a9236bf05 | |
| ToppCell | Control-Endothelial|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.17e-06 | 193 | 159 | 7 | c5f9fe03e64c211d4bcd4959e5b32f14841e336a | |
| ToppCell | Control-Endothelial-Endothelial-Gen_Cap|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.17e-06 | 193 | 159 | 7 | e1d546165dcc2392f540162206852c4717d7306f | |
| ToppCell | PCW_05-06-Mesenchymal|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 6.82e-06 | 196 | 159 | 7 | dca52c57ba35d9395cdbca8b881f12ece721b10f | |
| ToppCell | COPD-Multiplet-Multiplet|COPD / Disease state, Lineage and Cell class | 6.82e-06 | 196 | 159 | 7 | af4cdc61830685a888a1209826c23bcf54a43084 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-CD4/CD8-CD8_EM-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.82e-06 | 196 | 159 | 7 | 7e98380d815fbf6254289ace2af37aac6fef51e8 | |
| ToppCell | COPD-Multiplet|COPD / Disease state, Lineage and Cell class | 6.82e-06 | 196 | 159 | 7 | 6d02d494196e3f857d53eea46d9419690d43beca | |
| ToppCell | 3'_v3-GI_small-bowel-Lymphocytic_T_CD4/8-lo-Trm_Tgd|GI_small-bowel / Manually curated celltypes from each tissue | 6.82e-06 | 196 | 159 | 7 | 84cab9390794fe50203834b745722bf11c208ebd | |
| ToppCell | Parenchymal-NucSeq|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations | 7.29e-06 | 198 | 159 | 7 | 1996373bdccc55aac347d349bd22f6aad6d0c668 | |
| ToppCell | COVID-19-COVID-19_Mild-Myeloid-immature_Neutrophil|COVID-19_Mild / Disease, condition lineage and cell class | 7.53e-06 | 199 | 159 | 7 | e222b90caf45904d8f763574e7b6aac13333df92 | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-FOXM1|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 7.78e-06 | 200 | 159 | 7 | 4cfe08878a6981bf7b3567f9e82192d8f060ddde | |
| ToppCell | TCGA-Peripheral_Nervous_System-Primary_Tumor-Paraganglioma-Paraganglioma-3|TCGA-Peripheral_Nervous_System / Sample_Type by Project: Shred V9 | 9.14e-06 | 135 | 159 | 6 | ac20133d4a36f48338b45bffb13e842cb66f83ad | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.49e-05 | 147 | 159 | 6 | 989a48bda98fbff398985397a6b1189a4cbc80e7 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.49e-05 | 147 | 159 | 6 | f6681c849c4c06154548bd29a094f202d1c946c2 | |
| ToppCell | droplet-Lung-nan-3m-Myeloid-dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.80e-05 | 152 | 159 | 6 | 77b319f594d5e4df29034bbf69c7490076f89dd3 | |
| ToppCell | 390C-Fibroblasts-Fibroblast-B_(Myofibroblast)-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 2.40e-05 | 160 | 159 | 6 | 636127753e3a22831f39d4c8170df40901e4329d | |
| ToppCell | 390C-Fibroblasts-Fibroblast-B_(Myofibroblast)|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 2.40e-05 | 160 | 159 | 6 | cb8d0dc1a6c69c7a85c5fdd8f0f6cca1b73dfc63 | |
| ToppCell | PND10-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.66e-05 | 163 | 159 | 6 | 3efbbdc9cb2613bb76d8c2f07cd4ec1a2c51a622 | |
| ToppCell | normal-na-Lymphocytic_NK-NK_bright-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 2.76e-05 | 164 | 159 | 6 | b5a91f2cbfad9a2bc38aea576085a37865df955d | |
| ToppCell | facs-Marrow-T-cells-3m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.48e-05 | 171 | 159 | 6 | 913bae728b5e653771a27c79a309eb023699f1d0 | |
| ToppCell | facs-Marrow-T-cells-3m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.48e-05 | 171 | 159 | 6 | f28b2336057e353b96a6ff4581ec9fd0ca0789d9 | |
| ToppCell | E18.5-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B-B-B_prolif|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.60e-05 | 172 | 159 | 6 | 76c06a968d3333441eed103abef1e636a1c3e7a1 | |
| ToppCell | 3'_v3-bone_marrow-Lymphocytic_B-GC_B_(I)|bone_marrow / Manually curated celltypes from each tissue | 3.72e-05 | 173 | 159 | 6 | 67f0f0bf88eab69987b71d96b864ed2b14975adb | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.22e-05 | 177 | 159 | 6 | 3e149bff1f1b393a7abe98984e37981c8296f95d | |
| ToppCell | Control|World / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.22e-05 | 177 | 159 | 6 | b8ff6940e31b749776e81ae4f5bbd577dba9749c | |
| ToppCell | Control-T/NK-NK|Control / Disease group,lineage and cell class （2021.01.30） | 4.36e-05 | 178 | 159 | 6 | 079fd19bdeed86bf985c4083af432432d66ad546 | |
| ToppCell | Thalamus-Endothelial-ENDOTHELIAL_STALK-Flt1_1|Thalamus / BrainAtlas - Mouse McCarroll V32 | 4.50e-05 | 109 | 159 | 5 | 4e4a884b8979f4ff8b232c1581ea78884dda29ed | |
| ToppCell | droplet-Heart-nan-3m-Endothelial-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.78e-05 | 181 | 159 | 6 | 92d44892bb15771f0ab5fe61879b204b0acbd9b3 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.78e-05 | 181 | 159 | 6 | 5f2d3a08577c440c944778d07aa993c6e7873f3d | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.78e-05 | 181 | 159 | 6 | c7c5f7d4c397b4613c772413a0a679377efffff3 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell_cycling-Cycling_Connecting_Tubule_Cell_G2M|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.93e-05 | 182 | 159 | 6 | 336cd05e46a741185ce3c59ee67a4b07fa6a5101 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c12-MKI67-TYROBP|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.08e-05 | 183 | 159 | 6 | 54782c2e23bbeca5b683aa931393b1118da4aa37 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)-Exc_L4_RORB_CACNG5|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.24e-05 | 184 | 159 | 6 | 658f2e522055e88c92bc482a845c40f8f5f1a8e3 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.24e-05 | 184 | 159 | 6 | 7294b379ce4cb8fa75e432559082f93cd106aaf5 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Endothelial-blood_vessel_EC-Fetal_arterial_EC|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.40e-05 | 185 | 159 | 6 | 602536a3308a848f106adcb0a83530997440c8f4 | |
| ToppCell | facs-Marrow-T-cells-3m-Lymphocytic-BM_CD8_+_CD4_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.56e-05 | 186 | 159 | 6 | 4dce1484653bb266e2305cbb306fb11eaf7892e2 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum_-18m-Neuronal-interneuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.56e-05 | 186 | 159 | 6 | a1ab273b01971d6a892912560d387685dd657179 | |
| ToppCell | facs-Marrow-T-cells-3m-Lymphocytic-mature_alpha-beta_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.56e-05 | 186 | 159 | 6 | e23e1246914e230369a716d0d666b98383bf8512 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum_-18m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.73e-05 | 187 | 159 | 6 | ef3c85c01bc3da408ae288b6e3096ad888a12e63 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Principal_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.73e-05 | 187 | 159 | 6 | f6217d0dd425eac76900b44a4e48f45475f3ac36 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.90e-05 | 188 | 159 | 6 | b21e93a70583c30d05c0833cd3d4d4bca44a039e | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.90e-05 | 188 | 159 | 6 | 874404a4fd9aa42873f6c53dc42da22d3b0fdb9e | |
| ToppCell | (0)_NK_CD160pos|World / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 6.08e-05 | 189 | 159 | 6 | 713991025bb92d38cb0507ff01fd91b48c8af45a | |
| ToppCell | COVID-19-Heart-EC_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.08e-05 | 189 | 159 | 6 | fe49852ba15f948b384d6b4c258927c70b741357 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.08e-05 | 189 | 159 | 6 | fc88c51ace7d883c01617f3f9b5fab70cc91cc09 | |
| ToppCell | E18.5-samps-Mesenchymal|E18.5-samps / Age Group, Lineage, Cell class and subclass | 6.08e-05 | 189 | 159 | 6 | 0c18d3de4720759cf802eefb4d0ddde2a9246a1a | |
| ToppCell | LPS_only-Endothelial-Endothelial-Alv_Cap|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.26e-05 | 190 | 159 | 6 | 474cbbab8f3b0a6881fa6c92edb78e43999f9ab0 | |
| ToppCell | PBMC-Severe-Myeloid-Neutrophil-Neutrophil-Neu_4|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 6.26e-05 | 190 | 159 | 6 | 3f0c7d130f66faea778fe567604edf1b4cdf85b3 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.44e-05 | 191 | 159 | 6 | b2c86cde341fe350143658c8a8a4a9edbce3f19b | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Mesenchymal-immature_mesenchymal_cell-cycling_stromal|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.44e-05 | 191 | 159 | 6 | 50854384fdaa0efa2e3227659d544ed09ac102f2 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.44e-05 | 191 | 159 | 6 | a90c8ab2077e52bbc998457c85a1b9867f9c8c93 | |
| ToppCell | COVID-19-Heart-EC_(POSTN)|Heart / Disease (COVID-19 only), tissue and cell type | 6.63e-05 | 192 | 159 | 6 | c0c34785a7bdf461722029b322e9184e3d9b3c26 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Activated_Alv_Cap|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.63e-05 | 192 | 159 | 6 | c618ede75dce3988c87a5b8f98d8e94e1dd66efd | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.63e-05 | 192 | 159 | 6 | 04f5a2e3dd6beff027b89d66eefdd92036e041af | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.63e-05 | 192 | 159 | 6 | c07d7b40b2aa4eb27ac85801c014a656e2fd01dc | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_myocytic-mes_immature_ASM1_(8)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 6.63e-05 | 192 | 159 | 6 | c4efc170852abbcf0c53c2b0f8a0cc9fe7f116c8 | |
| ToppCell | COVID-19-Heart-Fib_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 6.63e-05 | 192 | 159 | 6 | 60b1312e84f6d6448365a952469c506c00b5fe93 | |
| ToppCell | renal_cortex_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 6.63e-05 | 192 | 159 | 6 | e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a | |
| ToppCell | PBMC-Severe-Myeloid-Neutrophil-Neutrophil-Neu_4|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.63e-05 | 192 | 159 | 6 | c09dcc73ff9c3855a0f3d7bfa0d5c99c09a117f2 | |
| ToppCell | droplet-Thymus-nan-3m-Lymphocytic-DN_to_DP_transition,_dividing_(more_DN)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.83e-05 | 193 | 159 | 6 | 40eedc1490c113403bc7c12a6bdf976f4f8bca84 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.83e-05 | 193 | 159 | 6 | 02f633b016ab19bfa65bfd0cf32f000549a62148 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Gen_Cap|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.83e-05 | 193 | 159 | 6 | 6e1982d089a9de628e6006d23ff78a223fbd9f47 | |
| ToppCell | wk_20-22-Mesenchymal-Myofibro_&_SMC-Myofibro_2|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 6.83e-05 | 193 | 159 | 6 | 2f203f6f0c2135acb046c9351a633c3b5b254a46 | |
| ToppCell | LPS-antiTNF-Endothelial|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.83e-05 | 193 | 159 | 6 | 5122b1ffba42de190061be34ecdc6176f84e56a3 | |
| ToppCell | Mild_COVID-19-T/NK-NK|Mild_COVID-19 / Disease group,lineage and cell class （2021.01.30） | 6.83e-05 | 193 | 159 | 6 | 9c455d9d845fa230e9a61d9a5f9d6a2ccf5d7350 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro1_(4)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 7.02e-05 | 194 | 159 | 6 | 71d3c7448b1734de54187f902f65649f9283bd4c | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Gen_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.02e-05 | 194 | 159 | 6 | 0b9cd96fa0b616da7cc90e92ff71157e9bba518f | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.02e-05 | 194 | 159 | 6 | 4c1d13d8cb6fb424655c67755ee6dbaf59d6b418 | |
| ToppCell | IPF-Multiplet-Multiplet|IPF / Disease state, Lineage and Cell class | 7.22e-05 | 195 | 159 | 6 | fce0c29574bb7aab181b9c00feb42681e285d1f2 | |
| ToppCell | IPF-Multiplet|IPF / Disease state, Lineage and Cell class | 7.22e-05 | 195 | 159 | 6 | eacc0449ae6f3ad8002268cd061467684c6fb9a7 | |
| ToppCell | (0)_NK_cells-(0)_NK_CD160pos|(0)_NK_cells / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 7.22e-05 | 195 | 159 | 6 | 6cbeceb52bb207f3c074e57b5b3f7cfb24fd5877 | |
| ToppCell | COVID-19-Heart-EC_1|Heart / Disease (COVID-19 only), tissue and cell type | 7.22e-05 | 195 | 159 | 6 | 50a193475db1bb1e05b8590225a553688c372c14 | |
| ToppCell | 356C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0|356C / Donor, Lineage, Cell class and subclass (all cells) | 7.39e-05 | 121 | 159 | 5 | 4ec70ad316942d9ade7bbdbf0e117e7c52b59d90 | |
| ToppCell | COVID-19_Severe-Non-classical_Monocyte|COVID-19_Severe / disease group, cell group and cell class | 7.43e-05 | 196 | 159 | 6 | af9e8f5ef9d03862f707e105857309b55595b1b9 | |
| ToppCell | 3'_v3-GI_small-bowel-Lymphocytic_T_CD4/8-lo|GI_small-bowel / Manually curated celltypes from each tissue | 7.43e-05 | 196 | 159 | 6 | a54ec174461944229c98a0b48b4822a556191ccb | |
| ToppCell | 10x5'-Liver-Lymphocytic_NK-NK_CD56bright_CD16-|Liver / Manually curated celltypes from each tissue | 7.43e-05 | 196 | 159 | 6 | 4ad73515af265432235b698fceb0ba370ced3e52 | |
| ToppCell | Fetal_29-31_weeks-Endothelial-capillary_endothelial_cell_(Cap1)-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 7.64e-05 | 197 | 159 | 6 | b2b7f8dc8ca421441e4c99c4f5d18fbc1668d79f | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.64e-05 | 197 | 159 | 6 | 412cb5f37df57121ddd1492021445479c7cbccbf | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.86e-05 | 198 | 159 | 6 | c01091ef18e096d792ea2a7a715764a5b215355f | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.86e-05 | 198 | 159 | 6 | 6d18b45eda4014759e6dd282d78ffd28df8a6044 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.86e-05 | 198 | 159 | 6 | 4ca5ff320905ab4ff60ed90a5522227c782142a6 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-Pericytes|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.08e-05 | 199 | 159 | 6 | f1723cfd6fbb8c8903a3b167872ec8523e3be250 | |
| ToppCell | background|World / Sample and Cell Type and Tumor Cluster (all cells) | 8.08e-05 | 199 | 159 | 6 | 5a6d0e00bfe1351eea192b54020bedeef78854e9 | |
| Drug | APETx1, Anthopleura elegantissima | 6.58e-06 | 6 | 159 | 3 | ctd:C475726 | |
| Drug | 17-AAG; Down 200; 1uM; MCF7; HT_HG-U133A | 7.87e-06 | 190 | 159 | 9 | 5586_DN | |
| Drug | 17-AAG; Down 200; 1uM; MCF7; HT_HG-U133A | 8.56e-06 | 192 | 159 | 9 | 5222_DN | |
| Drug | Todralazine hydrochloride [3778-76-5]; Down 200; 14.8uM; HL60; HT_HG-U133A | 1.01e-05 | 196 | 159 | 9 | 1841_DN | |
| Drug | 3-deazacytidine | 1.50e-05 | 206 | 159 | 9 | CID000001652 | |
| Disease | generalized epilepsy with febrile seizures plus 2 (implicated_via_orthology) | 9.25e-10 | 10 | 155 | 5 | DOID:0111294 (implicated_via_orthology) | |
| Disease | Dravet syndrome (implicated_via_orthology) | 9.25e-10 | 10 | 155 | 5 | DOID:0080422 (implicated_via_orthology) | |
| Disease | generalized epilepsy with febrile seizures plus (implicated_via_orthology) | 2.88e-09 | 12 | 155 | 5 | DOID:0060170 (implicated_via_orthology) | |
| Disease | bone quantitative ultrasound measurement | 1.87e-06 | 39 | 155 | 5 | EFO_0004514 | |
| Disease | QRS complex, QRS duration | 3.87e-06 | 45 | 155 | 5 | EFO_0005054, EFO_0005055 | |
| Disease | epilepsy (implicated_via_orthology) | 2.59e-05 | 163 | 155 | 7 | DOID:1826 (implicated_via_orthology) | |
| Disease | lung carcinoma, squamous cell carcinoma, gastric carcinoma | 2.74e-05 | 2 | 155 | 2 | EFO_0000178, EFO_0000707, EFO_0001071 | |
| Disease | salivary gland cancer (implicated_via_orthology) | 2.74e-05 | 2 | 155 | 2 | DOID:8850 (implicated_via_orthology) | |
| Disease | Primary Erythermalgia | 8.20e-05 | 3 | 155 | 2 | C0014805 | |
| Disease | PAROXYSMAL EXTREME PAIN DISORDER | 8.20e-05 | 3 | 155 | 2 | C1833661 | |
| Disease | Profound Mental Retardation | 9.64e-05 | 139 | 155 | 6 | C0020796 | |
| Disease | Mental Retardation, Psychosocial | 9.64e-05 | 139 | 155 | 6 | C0025363 | |
| Disease | Mental deficiency | 9.64e-05 | 139 | 155 | 6 | C0917816 | |
| Disease | urate measurement, bone density | SEM1 ERC1 PSD3 TIAM2 ITPKB THAP4 STRN HELZ2 UGGT2 PEAK1 G6PC1 DNAH11 | 1.11e-04 | 619 | 155 | 12 | EFO_0003923, EFO_0004531 |
| Disease | Kartagener syndrome (is_implicated_in) | 1.63e-04 | 4 | 155 | 2 | DOID:0050144 (is_implicated_in) | |
| Disease | interleukin 12 measurement | 1.76e-04 | 53 | 155 | 4 | EFO_0004753 | |
| Disease | Immunologic Deficiency Syndromes | 2.33e-04 | 23 | 155 | 3 | C0021051 | |
| Disease | Colorectal Carcinoma | DPYD NTHL1 POLE WRN RET ERI2 PREX2 HPS3 NDST3 SACS SETBP1 MKI67 | 3.52e-04 | 702 | 155 | 12 | C0009402 |
| Disease | Hereditary non-polyposis colorectal cancer syndrome | 3.79e-04 | 27 | 155 | 3 | C1112155 | |
| Disease | v-set and transmembrane domain-containing protein 4 measurement | 4.06e-04 | 6 | 155 | 2 | EFO_0803247 | |
| Disease | retinal degeneration (biomarker_via_orthology) | 4.23e-04 | 28 | 155 | 3 | DOID:8466 (biomarker_via_orthology) | |
| Disease | Hereditary Nonpolyposis Colorectal Cancer | 4.70e-04 | 29 | 155 | 3 | C1333990 | |
| Disease | Congenital Pain Insensitivity | 5.66e-04 | 7 | 155 | 2 | C0002768 | |
| Disease | alpha 1-antitrypsin deficiency (implicated_via_orthology) | 5.66e-04 | 7 | 155 | 2 | DOID:13372 (implicated_via_orthology) | |
| Disease | Hereditary Sensory Autonomic Neuropathy, Type 5 | 5.66e-04 | 7 | 155 | 2 | C0020075 | |
| Disease | Intellectual Disability | 6.22e-04 | 447 | 155 | 9 | C3714756 | |
| Disease | Early Childhood Epilepsy, Myoclonic | 7.52e-04 | 8 | 155 | 2 | C0393695 | |
| Disease | Idiopathic Myoclonic Epilepsy | 7.52e-04 | 8 | 155 | 2 | C0338478 | |
| Disease | Symptomatic Myoclonic Epilepsy | 7.52e-04 | 8 | 155 | 2 | C0338479 | |
| Disease | pneumococcal meningitis | 7.52e-04 | 8 | 155 | 2 | EFO_1001114 | |
| Disease | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 2 measurement | 7.52e-04 | 8 | 155 | 2 | EFO_0801373 | |
| Disease | Benign Infantile Myoclonic Epilepsy | 7.52e-04 | 8 | 155 | 2 | C0751120 | |
| Disease | Myoclonic Encephalopathy | 7.52e-04 | 8 | 155 | 2 | C0438414 | |
| Disease | Myoclonic Absence Epilepsy | 7.52e-04 | 8 | 155 | 2 | C0393703 | |
| Disease | endometrial cancer (is_implicated_in) | 8.94e-04 | 36 | 155 | 3 | DOID:1380 (is_implicated_in) | |
| Disease | synaptotagmin-11 measurement | 9.63e-04 | 9 | 155 | 2 | EFO_0802108 | |
| Disease | Myoclonic Epilepsy | 9.63e-04 | 9 | 155 | 2 | C0014550 | |
| Disease | tumor necrosis factor ligand superfamily member 14 measurement | 9.63e-04 | 9 | 155 | 2 | EFO_0010613 | |
| Disease | visceral heterotaxy (implicated_via_orthology) | 9.69e-04 | 37 | 155 | 3 | DOID:0050545 (implicated_via_orthology) | |
| Disease | Uterine Cancer | 1.20e-03 | 10 | 155 | 2 | C0153567 | |
| Disease | DNA-directed RNA polymerases I and III subunit RPAC1 measurement | 1.20e-03 | 10 | 155 | 2 | EFO_0801535 | |
| Disease | OCIA domain-containing protein 1 measurement | 1.20e-03 | 10 | 155 | 2 | EFO_0008252 | |
| Disease | Epilepsy, Myoclonic, Infantile | 1.20e-03 | 10 | 155 | 2 | C0917800 | |
| Disease | Semantic-Pragmatic Disorder | 1.46e-03 | 11 | 155 | 2 | C0454655 | |
| Disease | T-cell acute lymphoblastic leukemia (is_implicated_in) | 1.46e-03 | 11 | 155 | 2 | DOID:5603 (is_implicated_in) | |
| Disease | Auditory Processing Disorder, Central | 1.46e-03 | 11 | 155 | 2 | C0751257 | |
| Disease | Language Delay | 1.46e-03 | 11 | 155 | 2 | C0023012 | |
| Disease | Language Development Disorders | 1.46e-03 | 11 | 155 | 2 | C0023014 | |
| Disease | Myoclonic Astatic Epilepsy | 1.46e-03 | 11 | 155 | 2 | C0393702 | |
| Disease | Speech Delay | 1.46e-03 | 11 | 155 | 2 | C0241210 | |
| Disease | neuroimaging measurement | SEM1 RALGPS2 FGFRL1 JAK1 PTPN4 STRN NFIA RALGPS1 CC2D2A MAEL ARHGAP27 RAPGEF2 PLCE1 DNAH11 | 1.57e-03 | 1069 | 155 | 14 | EFO_0004346 |
| Disease | Adenocarcinoma of large intestine | 1.67e-03 | 96 | 155 | 4 | C1319315 | |
| Disease | endometrial carcinoma (is_implicated_in) | 1.75e-03 | 12 | 155 | 2 | DOID:2871 (is_implicated_in) | |
| Disease | protein CEI measurement | 1.75e-03 | 12 | 155 | 2 | EFO_0801936 | |
| Disease | oncostatin-M measurement | 1.75e-03 | 12 | 155 | 2 | EFO_0010792 | |
| Disease | tyrosine-protein kinase ZAP-70 measurement | 1.75e-03 | 12 | 155 | 2 | EFO_0020833 | |
| Disease | cortical surface area measurement | SEM1 RALGPS2 RASGEF1A FGFRL1 FOCAD STRN NFIA TBC1D22A RALGPS1 RASGEF1B MAEL ARHGAP27 TAF5 MCTP2 PLCE1 DNAH11 | 1.97e-03 | 1345 | 155 | 16 | EFO_0010736 |
| Disease | Infantile Severe Myoclonic Epilepsy | 2.06e-03 | 13 | 155 | 2 | C0751122 | |
| Disease | Leukemia, Myelocytic, Acute | 2.25e-03 | 173 | 155 | 5 | C0023467 | |
| Disease | cortical thickness | INHBA SEM1 RALGPS2 FGFRL1 MSH3 SPECC1 STRN VPS13D MRO NFIA TBC1D22A RALGPS1 MAEL PLCE1 | 2.28e-03 | 1113 | 155 | 14 | EFO_0004840 |
| Disease | Kartagener syndrome (implicated_via_orthology) | 2.39e-03 | 14 | 155 | 2 | DOID:0050144 (implicated_via_orthology) | |
| Disease | severe acute respiratory syndrome, COVID-19 | 2.59e-03 | 447 | 155 | 8 | EFO_0000694, MONDO_0100096 | |
| Disease | brain measurement, neuroimaging measurement | 2.59e-03 | 550 | 155 | 9 | EFO_0004346, EFO_0004464 | |
| Disease | generalised epilepsy | 2.60e-03 | 52 | 155 | 3 | EFO_0005917 | |
| Disease | Peripheral Nervous System Diseases | 2.90e-03 | 54 | 155 | 3 | C4721453 | |
| Disease | 4-acetamidobutanoate measurement | 3.13e-03 | 16 | 155 | 2 | EFO_0021003 | |
| Disease | Polyposis, Adenomatous Intestinal | 3.13e-03 | 16 | 155 | 2 | C2713442 | |
| Disease | Familial Intestinal Polyposis | 3.13e-03 | 16 | 155 | 2 | C2713443 | |
| Disease | Antibody Deficiency Syndrome | 3.54e-03 | 17 | 155 | 2 | C0003257 | |
| Disease | Adenomatous Polyposis Coli | 3.54e-03 | 17 | 155 | 2 | C0032580 | |
| Disease | ferritin measurement | 3.64e-03 | 119 | 155 | 4 | EFO_0004459 | |
| Disease | colorectal cancer (is_implicated_in) | 3.87e-03 | 121 | 155 | 4 | DOID:9256 (is_implicated_in) | |
| Disease | Malignant neoplasm of endometrium | 3.97e-03 | 18 | 155 | 2 | C0007103 | |
| Disease | Carcinoma in situ of endometrium | 3.97e-03 | 18 | 155 | 2 | C0346191 | |
| Disease | myeloid white cell count | PIEZO1 PCGF3 ABCA7 LIN9 PREX2 ZBTB7A CMIP NFIA SUPT5H C3 RAPGEFL1 PLCE1 | 4.03e-03 | 937 | 155 | 12 | EFO_0007988 |
| Disease | pursuit maintenance gain measurement | 4.10e-03 | 123 | 155 | 4 | EFO_0008433 | |
| Disease | brain volume measurement | 4.34e-03 | 595 | 155 | 9 | EFO_0006930 | |
| Disease | Hereditary Non-Polyposis Colon Cancer Type 2 | 4.42e-03 | 19 | 155 | 2 | C1333991 | |
| Disease | Colorectal cancer, hereditary nonpolyposis, type 1 | 4.42e-03 | 19 | 155 | 2 | C2936783 | |
| Disease | late-onset Alzheimers disease | 4.56e-03 | 292 | 155 | 6 | EFO_1001870 | |
| Disease | Malignant Neoplasms | 4.72e-03 | 128 | 155 | 4 | C0006826 | |
| Disease | level of Phosphatidylcholine (16:0_18:2) in blood serum | 4.90e-03 | 20 | 155 | 2 | OBA_2045071 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| RTPTKKEKDQAWKTL | 406 | O75528 | |
| KRKQLLKPVFLNSWI | 166 | A8K979 | |
| LTKFDLKQWLSATKP | 1766 | Q9HCE0 | |
| LGRLRFKKPQSLTKW | 66 | P06276 | |
| KRVNRPQASAWKKLE | 786 | Q9HCK8 | |
| TATFWRNKKSNKVLP | 721 | Q96JP9 | |
| PWKRIVAVSAKKKNS | 51 | Q15078 | |
| WFSPRSKKVRYVVSK | 146 | Q99728 | |
| PVLVRKRAFVKWENK | 716 | O95267 | |
| FKKKSDTWRLVNPPA | 896 | Q9UK96 | |
| LCTRKPEQKQRWLKA | 586 | Q9NR80 | |
| KKVLSNPSRWEVVLK | 166 | Q8IY22 | |
| LLNKFLTTAKDKNRW | 1206 | P01024 | |
| TRAWKPQSKLSVERK | 936 | Q5M775 | |
| NRKLFKANPSLDTWK | 891 | Q96DT5 | |
| KVKEALSPIKFNRWG | 446 | Q12882 | |
| LPWKKILIFEKRQDS | 46 | Q8N6F7 | |
| ANSRTKLLWPKRESL | 406 | O76090 | |
| PALKDRKWQIFKTSA | 146 | P40616 | |
| PLWKFQNDKAKRLSV | 321 | Q9UI46 | |
| LWKSKFSPENTRKEL | 256 | P01008 | |
| GKSPKQFLIDWVRKN | 376 | Q7Z478 | |
| PRLVRQGLKTKKWVN | 1396 | Q8IZY2 | |
| ENRFRTLKWLISPVK | 401 | Q8NCD3 | |
| WLFLKVPKANRTRTK | 156 | P08476 | |
| AKFVSQKISKTRWRP | 6 | Q8NFH3 | |
| WSKEKTCDRLPKFLV | 586 | O95803 | |
| LSEKPEVKQKWASRL | 61 | Q12857 | |
| IKTFWSPELKKERAL | 186 | Q8IUD2 | |
| LKFVVVTRWRFKKAP | 216 | Q3KNV8 | |
| FWLKSAKVPERKLQA | 56 | Q14978 | |
| KLQQTSCRKRDWKKP | 71 | Q99969 | |
| KTLLKEGRKPALSSW | 441 | Q5JS13 | |
| RKSDVLTTPWKFKVA | 681 | P23458 | |
| NTFPWLKIVKISFKC | 251 | P29074 | |
| KTLRKEWLLATSKPF | 276 | Q9NXK6 | |
| KVKPTRAVKDQRTWT | 126 | Q9UM07 | |
| FGRRKLKKWVTQPLL | 571 | P20585 | |
| WLDPSKEIKKQIRSS | 151 | Q9H4G0 | |
| KEIKKQIRSSPWNFA | 156 | Q9H4G0 | |
| KETFLTQKLRVPAKW | 1601 | P52948 | |
| SRWIKDLNVKPKTIK | 961 | O00370 | |
| PRKLWKIVESDQFKS | 81 | Q96LI6 | |
| PNLKTRKLTRVEWGK | 151 | Q5TKA1 | |
| LVWGINKFTKKLRSP | 941 | Q6DN14 | |
| LIWGINKFTKKLRNP | 821 | Q6DN12 | |
| KFLKEPSKTWIRSLL | 256 | Q96JY0 | |
| KTTSWLDPRLAKKAK | 326 | Q86UL8 | |
| SPQWLKELKSKKRQS | 1786 | Q9BY89 | |
| AIKTAPAIVWRLAKK | 356 | O60721 | |
| WVLKRKRTPQSDLKG | 696 | A6NM62 | |
| FISPKRWQKIFKSRL | 26 | P51572 | |
| KPKKFEDRVLALTSW | 36 | Q8ND23 | |
| AAEPRKKKWTLSLKN | 196 | Q8N441 | |
| RSLSPSKRGFKWKDN | 466 | Q1X8D7 | |
| FVDKKWNTIPLRNKS | 286 | Q9H792 | |
| RAADAKPKRWISFKS | 916 | Q9H792 | |
| WIKPTQKSRIIKSDA | 3026 | Q6ZR08 | |
| PKTKIFQFLKLTTWI | 436 | P63132 | |
| GLWKSRFQPENTKKR | 191 | P07093 | |
| FSKVSWKLRFQKREP | 31 | Q9BYG7 | |
| AEPTVRKHFLRKWLK | 1101 | Q07864 | |
| TSTKQWPKRSLRKAD | 1141 | P46013 | |
| PVSRLKKTWAKVKTA | 316 | Q0VAM2 | |
| RWKQAAKQRLTPKLF | 156 | Q9Y3T9 | |
| PKTKIFQFLKLTTWI | 436 | P63135 | |
| PKTKIFQFLKLTTWI | 436 | Q9BXR3 | |
| FKLRSTWDEIFPLKK | 116 | O94913 | |
| VKLSWNEKKFRPLSS | 156 | Q13415 | |
| PKTKIFQFLKLTTWI | 436 | Q9QC07 | |
| ISLWPRKQKRRKTEQ | 96 | P0CG42 | |
| KGLKVLKWNFTTPRD | 1176 | Q14008 | |
| ELTKIPIFSLFRKWK | 266 | Q9C0G6 | |
| RINFDVTRPKLWKSF | 1451 | Q9P2K1 | |
| VTRPKLWKSFFSRSL | 1456 | Q9P2K1 | |
| LKLTVNRVIWKIAKP | 41 | Q4AC94 | |
| RESCKGKLSKWLPFR | 281 | P35575 | |
| PSALRIAKKKRWNSI | 136 | Q9UNE7 | |
| KTKFRLPVFNWTALK | 566 | Q8IVF7 | |
| AKKLDAKTPSQRNKW | 951 | Q8IVF7 | |
| KAWRQKRSSVLKPLL | 991 | Q3T8J9 | |
| IKPTSKEFRKTWGFR | 16 | Q9BTC0 | |
| ESKRPKNTWQIRKFL | 356 | Q8IY85 | |
| KSLDQQIKDWLSPKR | 531 | Q96JA4 | |
| WARSKPIVNFKDDLK | 796 | Q8NFN8 | |
| IEPVWFSLARKKAKA | 1686 | Q9ULL0 | |
| VSWKRPQYSQKRTKE | 2381 | Q5TBA9 | |
| DLDQRPTKSWLKKFL | 2571 | Q9BYK8 | |
| LPFLLKQHKVWRKCS | 926 | Q9UHW9 | |
| EKLTWPNADSKKRIR | 446 | Q8WUM9 | |
| KINWSKQQKRLRKFP | 1601 | Q9NZJ4 | |
| RKKIKPTSAWNLAQK | 651 | P54277 | |
| TSRSIKKRLSIPQWY | 551 | Q8TDX9 | |
| LSLRVLPEFKKKAVW | 1781 | Q5VW36 | |
| TRKPSKKSRWNVLKC | 366 | P0C7A2 | |
| QRRPSQFDKKILLWT | 66 | Q5T6X4 | |
| LRFPWRETKKISFSK | 816 | Q12923 | |
| KVWKQRISSPLFNTK | 996 | O15294 | |
| PIFRLTKTWALLSRK | 151 | Q86X27 | |
| AKRLSPKRFRAKSSW | 696 | Q7Z2Y5 | |
| AILKSRKPSRWLQTF | 591 | Q2TAK8 | |
| RFWKSKAREVSKKPA | 36 | Q9GZR2 | |
| WGNKKLKQTFLSVLR | 281 | P59538 | |
| VWSVTPKKLRSVKQA | 496 | Q15542 | |
| SRLALTWEKLPSKFK | 876 | Q8WZA2 | |
| KSWKALTLSQKRPYV | 81 | Q9BT81 | |
| KDALRKTWNPKFTLR | 446 | O43815 | |
| TLWKTKQPEAKQRLL | 696 | Q8IYL2 | |
| FRLLRVFKLAKSWPT | 671 | P35499 | |
| KLTSQYIWRLSKRQP | 801 | Q969F9 | |
| RKSSLKDKSRWQFII | 796 | Q9P212 | |
| TLDQQKPRVSKSWRK | 636 | P27987 | |
| ANRLRWTKKATKSPE | 246 | P78549 | |
| LSWAPKDKSSRKNVL | 566 | Q6ZUM4 | |
| FITKIISKFPAWLKL | 611 | Q9C0D5 | |
| KKKWARSLTLSTAPL | 81 | Q6ZVN7 | |
| KDKSIRCSNWSKFPL | 191 | Q14191 | |
| DWRTKKPVVIRASKQ | 466 | Q9NSE4 | |
| ANLKPKSWVRLKRGI | 271 | O00267 | |
| WAKIIKNRKSGILSP | 71 | Q9HB31 | |
| PEVKQKWASRLLAKL | 66 | P08651 | |
| KLFLKRTAPFSILWT | 246 | A4IF30 | |
| KSLKRNLSFVWKAPA | 121 | A0A1B0GV85 | |
| FRLLRVFKLAKSWPT | 861 | P35498 | |
| WTAIKKARAAVSPQK | 226 | Q9HCU9 | |
| IRGLLKFWPKTCSQK | 311 | Q15172 | |
| RERLSWPKFQSIKSK | 256 | Q8IVF2 | |
| PKTKIFQFLKLTTWI | 436 | P63136 | |
| RLRTTWEKLPNKYEK | 821 | Q9Y4G8 | |
| KLQAISWARTKKIPF | 381 | Q9NRF8 | |
| LLCILKRAPFKKSWA | 86 | P32971 | |
| NLSPVARLKKTWSKV | 321 | Q8N9B8 | |
| WTGSLSRKKRKLQEP | 386 | Q8IVF5 | |
| KQLVKRWAELPKDTF | 91 | P06133 | |
| IWRQPESKTKLSFKV | 546 | P30825 | |
| LRVFKLAKSWPTLNT | 761 | Q9Y5Y9 | |
| PKTKIFQFLKLTTWI | 436 | P10266 | |
| PKTKIFQFLKLTTWI | 436 | P63133 | |
| FRLRKKTWKNPGTVF | 1176 | Q96K76 | |
| KIQKKLTPFWERCKL | 981 | Q9BY07 | |
| FRLLRVFKLAKSWPT | 846 | Q9UQD0 | |
| FSRVLKNRAWPTFKQ | 906 | Q70Z35 | |
| KNRAWPTFKQAKSKI | 911 | Q70Z35 | |
| TTKNWLGYTKKRAPI | 391 | Q9H9C1 | |
| ARKQFWKRSNSKLPG | 6 | Q8WUA7 | |
| VKIAWKTAAARKSLP | 466 | Q9BZ95 | |
| TQRTYLQWPKEKSKR | 756 | Q9Y2C9 | |
| KWEFPRKNLVLGKTL | 716 | P07949 | |
| RKLLKPRSIQKSWFV | 131 | O60290 | |
| VADRFPKKAWRQKRS | 441 | Q9H869 | |
| WVLLKKFKLPRNHES | 81 | Q8NEG5 | |
| LLNSESKKPRWPFSK | 216 | Q6ZR37 | |
| SFRVLRVFKLAKSWP | 671 | Q9UI33 | |
| RVFKLAKSWPTLNTL | 676 | Q9UI33 | |
| KLKLQKASERWQPDT | 461 | Q12874 | |
| KDAFKKTWNPKFTLR | 421 | Q9NRL3 | |
| RQFVKEKLLKWAESP | 531 | Q92508 | |
| LSVLRNTKTPVKFWL | 1251 | Q9NYU1 | |
| SAKLKRKKNWFGTAI | 26 | Q9H0M0 | |
| RLTWEKLPGKFKNLF | 531 | Q9UHV5 | |
| FAAKRRWTCSKPKPS | 526 | Q9Y6X0 | |
| RLKVSKPSLSWKELR | 1326 | Q68DK2 | |
| KKPNVFKLKTADWRV | 861 | Q9NYI0 | |
| RFPLKDSKRLIQWLK | 26 | Q8WY91 | |
| FKRTKHKWRIISPTL | 166 | Q9UBP6 | |
| RWIKSQKIVKFPRES | 1291 | Q8NFA0 | |
| LSVLKNTKTPVKFWF | 1276 | Q9NYU2 | |
| RVKINWLKSATKQPS | 336 | O94782 | |
| VERCTQALWKFIKPK | 116 | Q9HCK0 | |
| PAWSQKVEKKIRAKA | 366 | O95365 | |
| KFRRWKPKVAISKNC | 301 | Q5THJ4 | |
| DGSLQKKLKVWFRIP | 91 | Q9NRV9 | |
| ALVKWSVSKSAPRVK | 436 | Q9ULH4 |